Dallas Morcellator Lawsuits Filed for Cancer - Attorneys Handling Morcellator Cancer Lawsuits in Dallas Offer No-Cost, No-Obligation Morcellator Cancer Case Review to Residents of Dallas
Morcellator devices have been recalled by Johnson & Johnson’s Ethicon division due to the risk of spreading ovarian cancer. Power morcellators are used to perform hysterectomies and to remove ovarian fibroids in approximately 60,000 patients each year. Promoted as an improvement over open surgery, morcellators mince uterine tissues into small pieces that are removed via tiny incisions. In patients with preexisting uterine cancer, this process can scatter the cancer cells throughout the abdomen, transforming a manageable, localized cancer into an advanced-stage and fatal disease. The risk of morcellator cancer has been the subject of FDA warnings, FDA medical device committee hearings, and Ethicon market withdrawals, as well as warnings and bans issued by major hospitals, individual doctors, and national patient advocacy groups.
Johnson & Johnson, the primary manufacturer of morcellators used for ovarian surgery, has issued a global recall of three laparoscopic power morcellators: Gynecare Morcellex, Gynecare X-Tract, and Morcellex Sigma. The J&J morcellator recall represents yet another major product safety recall from one of the largest medical suppliers in the nation. Late in 2013, J&J announced it would pay a total of $2.5 billion to settle 8,000 hip implant recall cases resulting from product defects in its DePuy Orthapaedics line. J&J is currently facing approximately 30,000 lawsuits for defective pelvic mesh implants that cause severe harm in women. Despite these setbacks, J&J increased sales during 2013 by 6.1%, reporting annual sales of $71.3 billion.
Attorneys handling morcellator cancer lawsuits in Dallas believe that persons who were diagnosed with cancer after ovarian surgery may be entitled to compensation. If you or a loved one in Dallas underwent ovarian surgery such as hysterectomy or myomectomy and were later diagnosed with cancer, you may qualify. Evidence suggests that Johnson & Johnson and Ethicon officials were aware of the risks of morecellator cancer as early as 2006, yet waited to recall the device until 2014 when the company came under FDA pressure. Each lawsuit that is filed will serve to increase Johnson & Johnson’s accountability for the safety of its product. Dallas lawyers handling morcellator recall lawsuits provide no-cost, no-obligation case reviews to persons in Dallas. To learn if your case may qualify to file a Dallas morcellator lawsuit and to have your questions answered by an experienced morcellator attorney serving Dallas, contact our firm today.